Internationally Renowned UCSD Physician-Researcher Chosen as Distinguished Scientist by American Heart Association

 

December 03, 2010  |  

Michael H.Criqui, MD, MPH, FAHA, professor and chief of the Division of Preventive Medicine in the Department of Family and Preventive Medicine at the University of California, San Diego was honored as a Distinguished Scientist by the American Heart Association (AHA) at this year’s AHA Scientific Sessions in Chicago, Illinois.  This is the highest honor given by the AHA.

Michael Criqui

Dr. Michael Criqui was named 1 of 5 AHA Distinguished Scientists for 2010

In 2003, the American Heart Association created a Distinguished Scientist designation to honor AHA/ASA members who have made extraordinary contributions to cardiovascular and stroke research.   This title recognizes seminal research work that has importantly advanced the understanding and management of cardiovascular disease or stroke.

Criqui is one of five honorees this year to join the ranks of 65 other preeminent researchers and scientists.  He is an active and productive investigator in cardiovascular epidemiology and preventive cardiology, and has made seminal contributions in the fields of peripheral arterial disease, subclinical atherosclerosis and peripheral venous disease.  Criqui has published over 385 manuscripts and book chapters and has been an invited lecturer at numerous national and international meetings.

# # #

Media Contact: Kim Edwards, 619-543-6163, kedwards@ucsd.edu


Related Specialties



Media Contact

Share This Article


Related News

10/19/2017
University of California San Diego researchers have developed the first 3D spatial visualization tool for mapping “’omics” data onto whole organs. The tool helps researchers and clinicians understand ...
10/18/2017
Modeling the interplay between neurons and astrocytes derived from children with Autism Spectrum Disorder (ASD), researchers at University of California San Diego School of Medicine, with colleagues i ...
10/10/2017
Despite a diagnosis of stage IV pancreatic cancer and ongoing chemotherapy, Mike Levine boarded a plane this past weekend destined for Kona, Hawaii, where he will compete in one of the most grueling o ...
10/10/2017
Approximately 10 percent of Americans take a proton pump inhibitor drug to relieve symptoms of frequent heartburn and acid reflux. That percentage can be much higher for people with chronic liver dise ...



Follow Us